CD274 and neoplasm: Dysregulation of the PD-L1/PD-1 pathway is a mechanism by which malignant cells within the tumor microenvironment subvert protective antitumor immune responses by the host [5, 6], and PD-1/PD-L1 blockade is a promising anticancer strategy.